considering the good penetration of systemic high-dose ara-c ( hdara-c ) into the cns , we used this approach for treating overt meningeal leukemia , either isolated or with concurrent extraneurologic disease , in 15 adults with high-risk acute lymphoblastic leukemia ( all ) , one adult with lymphoid blast crisis of chronic granulocytic leukemia ( lbc-cgl ) , and four adults with poor-prognosis non-hodgkin 's lymphoma ( nhl ) .
C3714787
cns
C0948840
meningeal leukemia